vs

Side-by-side financial comparison of Cable One, Inc. (CABO) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $363.7M, roughly 1.3× Cable One, Inc.). On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -6.1%). Cable One, Inc. produced more free cash flow last quarter ($71.6M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -5.2%).

Cable One, Inc. is an American broadband communications provider. Under the Sparklight brand, it provides cable television, internet, and phone services to 24 U.S. states and 1.1 million residential and business customers. It also owns the Fidelity Communications brand, which provides the same services in Arkansas, Louisiana, Missouri, Oklahoma, and Texas. Fidelity was founded in 1940. It is headquartered in Phoenix, Arizona, though it does not serve that metro area.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CABO vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.3× larger
CLOV
$487.7M
$363.7M
CABO
Growing faster (revenue YoY)
CLOV
CLOV
+50.8% gap
CLOV
44.7%
-6.1%
CABO
More free cash flow
CABO
CABO
$140.5M more FCF
CABO
$71.6M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-5.2%
CABO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CABO
CABO
CLOV
CLOV
Revenue
$363.7M
$487.7M
Net Profit
$-49.3M
Gross Margin
Operating Margin
25.2%
-10.1%
Net Margin
-10.1%
Revenue YoY
-6.1%
44.7%
Net Profit YoY
-123.2%
EPS (diluted)
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CABO
CABO
CLOV
CLOV
Q4 25
$363.7M
$487.7M
Q3 25
$376.0M
$496.6M
Q2 25
$381.1M
$477.6M
Q1 25
$380.6M
$462.3M
Q4 24
$387.2M
$337.0M
Q3 24
$393.6M
$331.0M
Q2 24
$394.5M
$356.3M
Q1 24
$404.3M
$346.9M
Net Profit
CABO
CABO
CLOV
CLOV
Q4 25
$-49.3M
Q3 25
$86.5M
$-24.4M
Q2 25
$-438.0M
$-10.6M
Q1 25
$2.6M
$-1.3M
Q4 24
$-22.1M
Q3 24
$44.2M
$-9.2M
Q2 24
$38.2M
$7.4M
Q1 24
$37.4M
$-19.2M
Gross Margin
CABO
CABO
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CABO
CABO
CLOV
CLOV
Q4 25
25.2%
-10.1%
Q3 25
25.2%
-4.9%
Q2 25
-128.4%
-2.2%
Q1 25
25.1%
-0.3%
Q4 24
26.2%
-6.4%
Q3 24
28.0%
-2.7%
Q2 24
27.9%
2.0%
Q1 24
29.6%
-6.5%
Net Margin
CABO
CABO
CLOV
CLOV
Q4 25
-10.1%
Q3 25
23.0%
-4.9%
Q2 25
-114.9%
-2.2%
Q1 25
0.7%
-0.3%
Q4 24
-6.6%
Q3 24
11.2%
-2.8%
Q2 24
9.7%
2.1%
Q1 24
9.2%
-5.5%
EPS (diluted)
CABO
CABO
CLOV
CLOV
Q4 25
$-0.49
Q3 25
$14.52
Q2 25
$-77.70
Q1 25
$0.46
Q4 24
$-18.05
Q3 24
$7.58
Q2 24
$6.58
Q1 24
$6.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CABO
CABO
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$152.8M
$78.3M
Total DebtLower is stronger
$2.6B
Stockholders' EquityBook value
$1.4B
$308.7M
Total Assets
$5.6B
$541.0M
Debt / EquityLower = less leverage
1.81×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CABO
CABO
CLOV
CLOV
Q4 25
$152.8M
$78.3M
Q3 25
$166.6M
Q2 25
$152.9M
Q1 25
$149.1M
Q4 24
$153.6M
$194.5M
Q3 24
$226.6M
$288.0M
Q2 24
$201.5M
$254.8M
Q1 24
$210.7M
$208.3M
Total Debt
CABO
CABO
CLOV
CLOV
Q4 25
$2.6B
Q3 25
$2.7B
Q2 25
$2.9B
Q1 25
$3.0B
Q4 24
$3.6B
Q3 24
$3.5B
Q2 24
$3.5B
Q1 24
$3.6B
Stockholders' Equity
CABO
CABO
CLOV
CLOV
Q4 25
$1.4B
$308.7M
Q3 25
$1.4B
$340.9M
Q2 25
$1.3B
$344.2M
Q1 25
$1.8B
$336.1M
Q4 24
$1.8B
$341.1M
Q3 24
$1.9B
$342.2M
Q2 24
$1.9B
$324.9M
Q1 24
$1.9B
$292.5M
Total Assets
CABO
CABO
CLOV
CLOV
Q4 25
$5.6B
$541.0M
Q3 25
$5.7B
$559.7M
Q2 25
$5.8B
$575.0M
Q1 25
$6.4B
$583.7M
Q4 24
$6.5B
$580.7M
Q3 24
$6.7B
$653.0M
Q2 24
$6.7B
$674.2M
Q1 24
$6.7B
$671.8M
Debt / Equity
CABO
CABO
CLOV
CLOV
Q4 25
1.81×
Q3 25
1.88×
Q2 25
2.16×
Q1 25
1.66×
Q4 24
1.99×
Q3 24
1.84×
Q2 24
1.87×
Q1 24
1.93×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CABO
CABO
CLOV
CLOV
Operating Cash FlowLast quarter
$145.5M
$-66.9M
Free Cash FlowOCF − Capex
$71.6M
$-69.0M
FCF MarginFCF / Revenue
19.7%
-14.1%
Capex IntensityCapex / Revenue
20.3%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$278.1M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CABO
CABO
CLOV
CLOV
Q4 25
$145.5M
$-66.9M
Q3 25
$156.5M
$12.1M
Q2 25
$144.9M
$5.4M
Q1 25
$116.3M
$-16.3M
Q4 24
$167.6M
$34.8M
Q3 24
$176.2M
$50.0M
Q2 24
$155.5M
$44.8M
Q1 24
$164.8M
$25.9M
Free Cash Flow
CABO
CABO
CLOV
CLOV
Q4 25
$71.6M
$-69.0M
Q3 25
$84.8M
$11.4M
Q2 25
$76.6M
$4.8M
Q1 25
$45.2M
$-16.5M
Q4 24
$95.7M
$33.3M
Q3 24
$99.2M
$49.6M
Q2 24
$84.0M
$44.4M
Q1 24
$98.9M
$25.5M
FCF Margin
CABO
CABO
CLOV
CLOV
Q4 25
19.7%
-14.1%
Q3 25
22.5%
2.3%
Q2 25
20.1%
1.0%
Q1 25
11.9%
-3.6%
Q4 24
24.7%
9.9%
Q3 24
25.2%
15.0%
Q2 24
21.3%
12.5%
Q1 24
24.5%
7.3%
Capex Intensity
CABO
CABO
CLOV
CLOV
Q4 25
20.3%
0.4%
Q3 25
19.1%
0.1%
Q2 25
17.9%
0.1%
Q1 25
18.7%
0.0%
Q4 24
18.6%
0.5%
Q3 24
19.6%
0.1%
Q2 24
18.1%
0.1%
Q1 24
16.3%
0.1%
Cash Conversion
CABO
CABO
CLOV
CLOV
Q4 25
Q3 25
1.81×
Q2 25
Q1 25
44.62×
Q4 24
Q3 24
3.99×
Q2 24
4.08×
6.04×
Q1 24
4.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons